FDANonrulemakingFDA-2010-D-0530

Who commented on this docket

Draft Guidance for Industry on Principles for Considering Whether an FDA-Regulated Product Involves the Application of Nanotechnology; Availability

1 organizations filed 1 public comment on Draft Guidance for Industry on Principles for Considering Whether an FDA-Regulated Product Involves the Application of Nanotechnology; Availability, at the Food and Drug Administration. The comment window closed 5461d ago.

Organizations
1
Comments
1
RIN
Comment window
closed 5461d ago

Commenters (1)

View this docket on regulations.gov →

Attribution is name-based and imperfect. regulations.gov data is public record.